The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Wed., Jul. 29, 11:54 AM

Slide #12. Fibrocell Science, Inc Secondary Offering

Company: Fibrocell Science, Inc (NASDAQ:FCSC)
Date announced: 7/21/2015
Shares Offered: 2600000
Date of Pricing: 7/22/2015
Price Per Share: $5.80
Secondary Offering Details: Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet needs, today announced that it has commenced an underwritten public offering of its common stock pursuant to its existing shelf registration statement. All of the shares in the offering are to be sold by Fibrocell. - updated 7/22 - Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet needs, today announced the pricing of an underwritten public offering of 2.6 million shares of its common stock at a price of $5.80 per share. In addition, Fibrocell has granted the underwriters a 30-day option to purchase up to an additional 0.4 million shares of common stock.

Fibrocell Science is an autologous cell therapy company focused on developing treatments for skin diseases and conditions with unmet medical needs. Based on its proprietary autologous fibroblast technology, Co. is pursuing medical applications of azficel-T for restrictive burn scarring and vocal cord scarring. Co.'s clinical development programs are supported by a number of clinical trial programs at various stages of development. Co.'s medical development programs are designed to treat restrictive burn scars, vocal cord scarring and genetically-modified indications, for example recessive dystrophic epidermolysis bullosa. All Co.'s product candidates are non-surgical and minimally invasive.
Open the FCSC Page at The Online Investor »

Company Name:  Fibrocell Science, Inc.
Website:  www.fibrocellscience.com
Sector:  Biotechnology
Number of ETFs Holding FCSC:  12
Total Market Value Held by ETFs:  $3.66M
Total Market Capitalization:  $257.00M
% of Market Cap. Held by ETFs:  1.42%
 

Open the FCSC Page at The Online Investor (in a new window) »

July 29, 2015    11:54 AM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
95th percentile
(ranked higher than approx. 95% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.